<p>在过去一周，美国市场保持平稳，但过去一年上涨了 30%，预计年均盈利增长为 16%。在这种环境下，内部持股比例高的成长型公司尤其吸引人，因为它们通常反映了管理层对业务前景的信心以及与股东利益的一致性。</p>
<h3>美国内部持股比例高的十大成长型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>盈利增长</strong></td>
</tr>
<tr>
<td>优信 (UXIN)</td>
<td>35.7%</td>
<td>74.1%</td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>12.8%</td>
<td>53.6%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17%</td>
<td>53.2%</td>
</tr>
<tr>
<td>Enovix (ENVX)</td>
<td>12.4%</td>
<td>41.1%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>12%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>29.6%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>19.3%</td>
<td>104%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.8%</td>
<td>27.8%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>22.1%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们关于内部持股比例高的快速成长美国公司的 202 只股票的完整列表。</p>
<p>以下是筛选器中一些选择的预览。</p>
<h2>Prenetics Global (PRE)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Prenetics Global Limited 是一家健康科学公司，专注于在香港、美国及国际上推动消费者健康，市值约为 3.0847 亿美元。</p>
<p><strong>运营：</strong> Prenetics Global Limited 通过其健康科学业务产生收入，旨在提升香港、美国及其他国际市场的消费者健康。</p>
<p><strong>内部持股比例：</strong> 25.6%</p>
<p><strong>收入增长预测：</strong> 年均 53.9%。</p>
<p>Prenetics Global 的增长前景良好，预计年均收入增长 53.9%，超过美国市场平均水平。尽管近期股东稀释和股价波动，该公司的交易价格显著低于其估计的公允价值。Prenetics 与 Superpower 的战略合作增强了其健康产品，而 4000 万美元的股票回购反映了对未来前景的信心。然而，它面临着现金流有限和持续净亏损的挑战，尽管预计在三年内实现盈利。</p>
<ul>
<li>通过阅读我们的分析师估计报告，深入了解 Prenetics Global 的表现。</li>
<li>在审查我们最新的估值报告后，Prenetics Global 的股价可能过于悲观。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7c17bfca-7281-42b7-b56b-4bcb0840c624/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7c17bfca-7281-42b7-b56b-4bcb0840c624/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 4 月的 PRE 盈利和收入增长</p>
<h2>Precigen (PGEN)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Precigen, Inc.是一家发现和临床阶段的生物制药公司，专注于开发用于免疫肿瘤学、自身免疫疾病和传染病的基因和细胞疗法，市值为 14.6 亿美元。</p>
<p><strong>运营：</strong> 公司的收入部分包括生物技术（初创公司），产生了 968 万美元的收入。</p>
<p><strong>内部持股比例：</strong> 11.9%</p>
<p><strong>收入增长预测：</strong> 年均 39.6%。</p>
<p>Precigen 有望实现增长，预计年均收入增长 39.6%，超过美国市场。尽管 2025 年净亏损达到 2.5064 亿美元和近期股东稀释，但其交易价格显著低于估计的公允价值。近期内部活动显示买入多于卖出，表明对未来前景的信心。预计公司将在三年内实现盈利，支持其高达 48.9% 的预期股本回报率。</p>
<ul>
<li>在这份增长报告中解锁我们对 Precigen 股票分析的全面见解。</li>
<li>我们的 Precigen 估值报告中的分析暗示其股价可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fb7141f-fd80-4e2e-93e9-552be9c67d53/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fb7141f-fd80-4e2e-93e9-552be9c67d53/chart/ownership-breakdown"/></p>
<p>截至 2026 年 4 月的 PGEN 持股结构</p>
<h2>Diana Shipping (DSX)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Diana Shipping Inc.在全球提供航运运输服务，市值为 2.8933 亿美元。</p>
<p><strong>运营：</strong> 该公司从其干散货船业务中产生了 2.1354 亿美元的收入。</p>
<p><strong>内部持股比例：</strong> 29.3%</p>
<p><strong>收入增长预测：</strong> 年均 13.4%。</p>
<p>尽管财务状况面临挑战，Diana Shipping 显示出增长潜力，预计盈利将显著增长，年均 57.6%，超过美国市场。近期的租船协议将增强收入，尽管内部持股活动有限。该公司的交易价格略低于其估计的公允价值，并且股息记录不稳定。近期的船舶收购和租船表明战略扩张，但其股本回报率预计将保持在 11.7% 的低水平。</p>
<ul>
<li>点击探索我们在 Diana Shipping 盈利增长报告中的详细发现。</li>
<li>我们的估值报告揭示了 Diana Shipping 的股票可能以溢价交易的可能性。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/be860cf4-afc0-4806-b207-b8a9ead47806/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/be860cf4-afc0-4806-b207-b8a9ead47806/chart/ownership-breakdown"/></p>
<p>截至 2026 年 4 月的 DSX 持股结构</p>
<h2>利用机会</h2>
<ul>
<li>在这里浏览 202 个内部持股比例高的快速成长美国公司的完整清单。</li>
<li>对其他选择感到好奇？稀土金属是大多数高科技设备、军事和国防系统以及电动车的原材料。全球竞赛正在进行，以确保这些关键矿物的供应。抢先发现 32 只最佳稀土金属股票，这些股票是为数不多的开采这一重要战略资源的公司。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
<h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
<p>我们为股票投资者创建了 <strong>终极投资组合伴侣</strong>，<strong>而且是免费的。</strong></p>
<p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
<p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
<p>• 跟踪您股票的公允价值</p>
<p>免费试用演示投资组合</p>

UPST

优信

UPSX

<p>在 2026 年 4 月，美国市场保持平稳，但过去一年上涨了 30%，预计收益将以每年 16% 的速度增长。高内部持股的成长型公司受到关注，包括优信（35.7% 的持股比例，74.1% 的增长）、Upstart Holdings（12.8% 的持股比例，53.6% 的增长）和 Precigen（11.9% 的持股比例，68.4% 的增长）。Prenetics Global 和 Diana Shipping 也因其增长潜力而受到关注，尽管面临挑战。文章强调了内部持股作为商业前景信心指标的重要性</p>

<p>In the last week, the United States market has stayed flat, yet it is up 30% over the past year with earnings forecast to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often reflect management's confidence in their business prospects and alignment with shareholder interests.</p>
<div class="lb-trans"><p>在过去一周，美国市场保持平稳，但过去一年上涨了 30%，预计年均盈利增长为 16%。在这种环境下，内部持股比例高的成长型公司尤其吸引人，因为它们通常反映了管理层对业务前景的信心以及与股东利益的一致性。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In The United States</h3>
<div class="lb-trans"><h3>美国内部持股比例高的十大成长型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Uxin (UXIN)</td>
<td>35.7%</td>
<td>74.1%</td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>12.8%</td>
<td>53.6%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17%</td>
<td>53.2%</td>
</tr>
<tr>
<td>Enovix (ENVX)</td>
<td>12.4%</td>
<td>41.1%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>12%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>29.6%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>19.3%</td>
<td>104%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.8%</td>
<td>27.8%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>22.1%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>盈利增长</strong></td>
</tr>
<tr>
<td>优信 (UXIN)</td>
<td>35.7%</td>
<td>74.1%</td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>12.8%</td>
<td>53.6%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17%</td>
<td>53.2%</td>
</tr>
<tr>
<td>Enovix (ENVX)</td>
<td>12.4%</td>
<td>41.1%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>12%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>29.6%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>19.3%</td>
<td>104%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.8%</td>
<td>27.8%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>22.1%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 202 stocks from our Fast Growing US Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们关于内部持股比例高的快速成长美国公司的 202 只股票的完整列表。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是筛选器中一些选择的预览。</p>
</div><h2>Prenetics Global (PRE)</h2>
<div class="lb-trans"><h2>Prenetics Global (PRE)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Prenetics Global Limited is a health sciences company that focuses on advancing consumer health in Hong Kong, the United States, and internationally, with a market cap of approximately $308.47 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Prenetics Global Limited 是一家健康科学公司，专注于在香港、美国及国际上推动消费者健康，市值约为 3.0847 亿美元。</p>
</div><p><strong>Operations:</strong> Prenetics Global Limited generates revenue through its health sciences operations aimed at enhancing consumer health across Hong Kong, the United States, and other international markets.</p>
<div class="lb-trans"><p><strong>运营：</strong> Prenetics Global Limited 通过其健康科学业务产生收入，旨在提升香港、美国及其他国际市场的消费者健康。</p>
</div><p><strong>Insider Ownership:</strong> 25.6%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 25.6%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 53.9% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 年均 53.9%。</p>
</div><p>Prenetics Global is positioned for growth with a forecasted 53.9% annual revenue increase, surpassing the US market average. Despite recent shareholder dilution and volatility in share price, the company trades significantly below its estimated fair value. Prenetics' strategic partnership with Superpower enhances its health offerings, while a $40 million share buyback reflects confidence in future prospects. However, it faces challenges such as limited cash runway and ongoing net losses despite expected profitability within three years.</p>
<div class="lb-trans"><p>Prenetics Global 的增长前景良好，预计年均收入增长 53.9%，超过美国市场平均水平。尽管近期股东稀释和股价波动，该公司的交易价格显著低于其估计的公允价值。Prenetics 与 Superpower 的战略合作增强了其健康产品，而 4000 万美元的股票回购反映了对未来前景的信心。然而，它面临着现金流有限和持续净亏损的挑战，尽管预计在三年内实现盈利。</p>
</div><ul>
<li>Get an in-depth perspective on Prenetics Global's performance by reading our analyst estimates report here.</li>
<li>Upon reviewing our latest valuation report, Prenetics Global's share price might be too pessimistic.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过阅读我们的分析师估计报告，深入了解 Prenetics Global 的表现。</li>
<li>在审查我们最新的估值报告后，Prenetics Global 的股价可能过于悲观。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7c17bfca-7281-42b7-b56b-4bcb0840c624/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/7c17bfca-7281-42b7-b56b-4bcb0840c624/chart/earnings-and-revenue-growth"/></p>
<p>PRE Earnings and Revenue Growth as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 PRE 盈利和收入增长</p>
</div><h2>Precigen (PGEN)</h2>
<div class="lb-trans"><h2>Precigen (PGEN)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company focused on developing gene and cell therapies for immuno-oncology, autoimmune disorders, and infectious diseases, with a market cap of $1.46 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Precigen, Inc.是一家发现和临床阶段的生物制药公司，专注于开发用于免疫肿瘤学、自身免疫疾病和传染病的基因和细胞疗法，市值为 14.6 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue segment includes Biotechnology (Startups), generating $9.68 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入部分包括生物技术（初创公司），产生了 968 万美元的收入。</p>
</div><p><strong>Insider Ownership:</strong> 11.9%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 11.9%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 39.6% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 年均 39.6%。</p>
</div><p>Precigen is poised for growth, with revenue expected to increase 39.6% annually, outpacing the US market. Despite a substantial net loss of US$250.64 million in 2025 and recent shareholder dilution, it trades significantly below estimated fair value. Insider activity shows more buying than selling recently, indicating confidence in its future prospects. The company is forecasted to achieve profitability within three years, supported by a high anticipated return on equity of 48.9%.</p>
<div class="lb-trans"><p>Precigen 有望实现增长，预计年均收入增长 39.6%，超过美国市场。尽管 2025 年净亏损达到 2.5064 亿美元和近期股东稀释，但其交易价格显著低于估计的公允价值。近期内部活动显示买入多于卖出，表明对未来前景的信心。预计公司将在三年内实现盈利，支持其高达 48.9% 的预期股本回报率。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Precigen stock in this growth report.</li>
<li>The analysis detailed in our Precigen valuation report hints at an inflated share price compared to its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这份增长报告中解锁我们对 Precigen 股票分析的全面见解。</li>
<li>我们的 Precigen 估值报告中的分析暗示其股价可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fb7141f-fd80-4e2e-93e9-552be9c67d53/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/0fb7141f-fd80-4e2e-93e9-552be9c67d53/chart/ownership-breakdown"/></p>
<p>PGEN Ownership Breakdown as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 PGEN 持股结构</p>
</div><h2>Diana Shipping (DSX)</h2>
<div class="lb-trans"><h2>Diana Shipping (DSX)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Diana Shipping Inc. provides shipping transportation services globally with a market cap of $289.33 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Diana Shipping Inc.在全球提供航运运输服务，市值为 2.8933 亿美元。</p>
</div><p><strong>Operations:</strong> The company generates revenue of $213.54 million from its dry-bulk vessels segment.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司从其干散货船业务中产生了 2.1354 亿美元的收入。</p>
</div><p><strong>Insider Ownership:</strong> 29.3%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 29.3%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 13.4% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 年均 13.4%。</p>
</div><p>Diana Shipping shows potential for growth despite a challenging financial position, with earnings expected to grow significantly at 57.6% per year, outpacing the US market. Recent charter agreements are set to bolster revenue, although insider ownership activity is limited. The company trades slightly below its estimated fair value and has an unstable dividend track record. Recent vessel acquisitions and charters indicate strategic expansion, but its return on equity is forecasted to remain low at 11.7%.</p>
<div class="lb-trans"><p>尽管财务状况面临挑战，Diana Shipping 显示出增长潜力，预计盈利将显著增长，年均 57.6%，超过美国市场。近期的租船协议将增强收入，尽管内部持股活动有限。该公司的交易价格略低于其估计的公允价值，并且股息记录不稳定。近期的船舶收购和租船表明战略扩张，但其股本回报率预计将保持在 11.7% 的低水平。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in Diana Shipping's earnings growth report.</li>
<li>Our valuation report unveils the possibility Diana Shipping's shares may be trading at a premium.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击探索我们在 Diana Shipping 盈利增长报告中的详细发现。</li>
<li>我们的估值报告揭示了 Diana Shipping 的股票可能以溢价交易的可能性。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/be860cf4-afc0-4806-b207-b8a9ead47806/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/be860cf4-afc0-4806-b207-b8a9ead47806/chart/ownership-breakdown"/></p>
<p>DSX Ownership Breakdown as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 DSX 持股结构</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用机会</h2>
</div><ul>
<li>Navigate through the entire inventory of 202 Fast Growing US Companies With High Insider Ownership here.</li>
<li>Curious About Other Options? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 32 best rare earth metal stocks of the very few that mine this essential strategic resource.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里浏览 202 个内部持股比例高的快速成长美国公司的完整清单。</li>
<li>对其他选择感到好奇？稀土金属是大多数高科技设备、军事和国防系统以及电动车的原材料。全球竞赛正在进行，以确保这些关键矿物的供应。抢先发现 32 只最佳稀土金属股票，这些股票是为数不多的开采这一重要战略资源的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我们为股票投资者创建了 <strong>终极投资组合伴侣</strong>，<strong>而且是免费的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟踪您股票的公允价值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免费试用演示投资组合</p>
</div>

2026 年 4 月拥有内部持股的顶级增长公司